Ann Partridge MD, MPH Profile
Ann Partridge MD, MPH

@AnnPartridgeMD

Followers
4K
Following
3K
Media
104
Statuses
813

Boston, MA
Joined July 2013
Don't wanna be here? Send us removal request.
@KimmieNgMD
Kimmie Ng, MD, MPH
22 days
What I strive to do every day in clinic! Definitely one of the best gifts I have gotten from a patient! @DanaFarber @DanaFarberNews @DFarberYoungCRC @ASCO
6
7
137
@PabloMando
Pablo Mando
5 months
It’s been an honor and privilege to have been part of the faculty of BCY at #ESMOBreast25 A growing community working for the young patients with BC. Thank you @matteolambe and Dr Paluch-Shimon 👏👏👏 @AnnPartridgeMD @KalinskyKevin @breastDoktor @RebeccaDSing @Icro_Meattini
1
3
45
@Lucarecco
Luca Arecco, MD
5 months
@matteolambe starts presenting the first results of the survey answered by 18 expert panelists focused in the treatment of young pts Topic 1: are we giving too much or not enough adjuvant OFS? Age and nodal involvement are main factors considered in deciding adj ET @OncoAlert
1
5
21
@TanjaSpanic
Tanja Spanic
5 months
Amazing start of #ESMObreastBCY with full room showing the importance and interest in care for young women with breast cancer 💕 @matteolambe @myESMO @AnnPartridgeMD @FAndreMD
2
6
26
@matteolambe
Matteo Lambertini, MD PhD
5 months
Great overview by @fedrophd on how to manage the side effects of estrogen deprivation therapy in young women with #BreastCancer during #ESMOBreastBCY…looking forward to new data expected at #ASCO25 on improving vasomotor symptoms @myESMO @OncoAlert #ESMOBreast25 #ESMOAmbassadors
0
11
31
@AnnPartridgeMD
Ann Partridge MD, MPH
5 months
Can’t miss CME opportunity!
@DFCI_BreastOnc
Dana-Farber’s Breast Oncology Center
5 months
📢 New @harvardmed CME Course! Updates to #CancerSurvivorship: Optimizing Care and Outcomes. Sign up for this on demand course and learn about current trends in cancer survivorship, the evolving role of providers after treatment, and strategies to meet the medical and emotional
2
3
27
@tess_omeara
Tess O'Meara, MD, MHS
6 months
Thanks to the incredible team at @FoundationATCG for making our project possible! Stay tuned for interesting correlates of response and resistance to T-DM1, T-DXd, and SG in the Flatiron database at ASCO 🙌🏻 #ADC #breastcancer @ASCO @ConquerCancerFd
@DFCI_BreastOnc
Dana-Farber’s Breast Oncology Center
6 months
Congratulations to Paolo Tarantino (@PTarantinoMD), Caterina Sposetti (@CateSposetti), Pietro De Placido (@PietroDePlacido) and Tess O'Meara (@tess_omeara) on receiving the prestigious #ConquerCancer @ASCO Merit Awards!
0
3
23
@matteolambe
Matteo Lambertini, MD PhD
7 months
Just published in @JCO_ASCO the updated @ASCO guidelines on fertility preservation in people with #cancer: a must read for all colleagues involved in cancer care to increase awareness on #oncofertility issues @OncoAlert @AnnPartridgeMD @oncofertility Link: https://t.co/ZBvawDBCzW
7
199
459
@FilipaLynce
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸
10 months
So proud of Dr. Caroline Block, recipient of the Arthur Skarin Award and Dr. Geoff Shapiro @GShapiroMDPhD, recipient of the Distinguished Researcher Award from the Massachusetts Society of Clinical Oncology @DFCI_BreastOnc @DanaFarber @DanaFarberBRCA @DanaFarber_CCTI 👏🏻👏🏻👏🏻
0
8
39
@MSCO_oncology
MSCO
11 months
🎉Big win for MA patients-saving lives, & reducing disparities! Starting 2026, breast imaging will be covered with NO out-of-pocket costs. Thank you to Gov. @maura_healey @DFCI_BreastOnc & all advocates! Together, we’re making a difference. #MACancerCares #BreastCancerAwareness
0
4
12
@DFCI_BreastOnc
Dana-Farber’s Breast Oncology Center
11 months
We are proud to announce that four of our #BreastCancer physician-scientists made the #HighlyCited2024 researchers list, released today by @ClarivateAG. Congratulations to ✨Dr. Myles Brown ✨Dr. Nancy Lin (@nlinmd) ✨Dr. Geoffrey Shapiro (@GShapiroMDPhD) ✨Dr. Sara Tolaney
1
12
41
@DanaFarberNews
Dana-Farber News
11 months
Congratulations @DavidBarbie8 and the @DFarberThoracic team! They were awarded a $2.5 million, four-year research grant from the @lcrf_org and the @IASLC. Read more here: https://t.co/0hzWcuegSg
2
11
66
@AnnPartridgeMD
Ann Partridge MD, MPH
11 months
congratulations Judy. So well-deserved.@ALLIANCE_org
@TheCancerLetter
The Cancer Letter
11 months
When Judith O. Hopkins started medical school in 1974, she had to sign a contract promising to not get pregnant. This was not the most egregious form of sexism she would face in her career. Seeking a residency in emergency medicine in 1977, she was told point blank that she
0
2
4
@VKaklamani
VIRGINIA KAKLAMANI
11 months
Not every day that a Nobel prize winner will be delivering a talk at @SABCSSanAntonio opening ceremony. Excited to hear his talk @kaelin_lab @CarlosArteagaMD @AACR @UTHealthSAMDA
@SABCSSanAntonio
SABCS
11 months
(Re)emerging Principles for Controlling Cancer with Drugs: William Kaelin will address this topic in a Keynote Address at #SABCS24 (December 10-13). Learn more: https://t.co/7CkZPvQF3G @kaelin_lab
1
11
33
@stolaney1
Sara Tolaney
11 months
The IBC forum is this morning-- a terrific program to learn more about inflammatory breast cancer. Thanks to @FilipaLynce and team for organizing! All are welcome: https://t.co/HcuoKPuybU @DFCI_BreastOnc @DanaFarberNews #bcsm
2
10
41
@DFCI_BreastOnc
Dana-Farber’s Breast Oncology Center
11 months
New 📰 on patient-reported outcomes, and perceptions and knowledge about recurrence in women with hormone receptor-positive #BreastCancer. 👉 https://t.co/5C101F8ECB ✍️@ShoshRosenberg @nlinmd @AnnPartridgeMD @DrEricWiner @hthrparsons #survivorship
0
17
40
@YaleCancer
Yale Cancer Center
11 months
Thank you to @AnnPartridgeMD @harvardmed @DanaFarber for joining us to present #GrandRounds on the care of young adults with #breastcancer and the unique challenges they face. Watch her talk now https://t.co/DEWcBzDFAd. #bcsm @SmilowCancer @YaleMed @YNHH @YaleBreast
2
15
123
@DFCI_BreastOnc
Dana-Farber’s Breast Oncology Center
1 year
The open-label, international, multicenter, randomized phase III AFT-65/ASCENT-05/OptimICE-RD trial will determine whether the combination of #SacituzumabGovitecan and #Pembrolizumab can improve iDFS compared with pembrolizumab, alone or in combination with capecitabine, in
0
9
30
@DanaFarber
Dana-Farber
1 year
Research by Dana-Farber Cancer Institute investigators has encouraging news for young women who have survived #BreastCancer and want to have children. #pregnancy #YoungAdultBreastCancer #BreastCancerAwareness @AnnPartridgeMD @DFCI_BreastOnc https://t.co/8pT0bii2cq
2
8
12
@nlinmd
Nancy Lin, MD
1 year
Powerhouse panel at the @BCRFcure symposium: Drs. Larry Norton, @DrLisaCarey, Robert Vonderheide, Abenaa Brewster, and Judy Garber. Thank you to BCRF for your incredible support of breast cancer research!
0
8
31